Magnetar Financial LLC purchased a new position in HCM II Acquisition Corp. (NASDAQ:HOND - Free Report) in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund purchased 1,959,198 shares of the company's stock, valued at approximately $20,719,000. Magnetar Financial LLC owned about 6.81% of HCM II Acquisition at the end of the most recent reporting period.
A number of other institutional investors and hedge funds also recently made changes to their positions in the stock. Mizuho Securities USA LLC acquired a new stake in shares of HCM II Acquisition in the first quarter worth about $271,000. Toronto Dominion Bank acquired a new stake in shares of HCM II Acquisition in the fourth quarter worth about $318,000. Schonfeld Strategic Advisors LLC acquired a new stake in shares of HCM II Acquisition in the fourth quarter worth about $752,000. TENOR CAPITAL MANAGEMENT Co. L.P. acquired a new stake in shares of HCM II Acquisition in the fourth quarter worth about $1,745,000. Finally, Centiva Capital LP acquired a new stake in shares of HCM II Acquisition in the fourth quarter worth about $1,956,000.
HCM II Acquisition Price Performance
Shares of NASDAQ:HOND traded down $0.07 on Monday, reaching $11.70. The company had a trading volume of 177,380 shares, compared to its average volume of 667,971. HCM II Acquisition Corp. has a twelve month low of $9.90 and a twelve month high of $12.24. The stock has a 50-day moving average price of $11.21 and a 200 day moving average price of $10.94.
HCM II Acquisition Profile
(
Free Report)
HCM II Acquisition Corp. operates as a blank check company. It was formed for the purpose of entering into a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on April 4, 2024 and is headquartered in Stamford, CT.
See Also

Before you consider HCM II Acquisition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HCM II Acquisition wasn't on the list.
While HCM II Acquisition currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.